ANDROGENETIC ALOPECIA

This early-phase trial tests a new treatment called EPI-001 for androgenetic alopecia (male/female pattern baldness). EPI-001 is made from a patient's own hair follicle cells and injected into the scalp. The study will enroll 42 adults to check safety and see if it can regrow hai…

This study tests an oral drug called VDPHL01 in 552 women aged 18–65 with mild to moderate hereditary hair loss. Participants take a pill once or twice daily for about 13 months. The goal is to see if it increases hair count and if women feel their hair looks better. It's a place…

This Phase 3 trial tests whether a daily 1 mg minoxidil pill works as well as the standard topical minoxidil solution for women with hormone-related hair loss. About 520 women will be randomly assigned to receive the oral pill, the topical solution, or a placebo for up to 36 week…

This study tests whether injections of secretome (a substance made by stem cells) can improve hair density and thickness in people with pattern baldness, compared to platelet-rich plasma (PRP) injections. The trial involves 40 men and women aged 25-59 with mild to moderate hair l…

This study tests if a once-daily 5% minoxidil foam can help women with androgenetic alopecia (female pattern hair loss) grow more hair. About 294 women aged 18 and older with mild to moderate hair loss will use either the foam or a placebo for 24 weeks. The main goal is to see if…

This study looks at whether a special shampoo can improve scalp health and reduce dandruff (seborrheic dermatitis) in 120 men aged 18-55 who have had a hair transplant. Some participants will use the test shampoo plus a basic shampoo, while others use only basic shampoo. The rese…

This study tests a new hair lotion (Finlândia) for men with male pattern baldness. About 190 men aged 18 to 60 who already use minoxidil will use the lotion for 6 months. Researchers will check if it increases hair density and monitor for side effects.

This study tests a special laser (1470nm) to see if it can safely help people with two types of hair loss: male/female pattern baldness and scarring alopecia. Ten adults with stable hair loss will receive the laser treatment. Researchers will measure hair counts and density using…

This study will measure a protein called JAK2 in the scalps of 25 people with male pattern baldness. Researchers will compare JAK2 levels in balding and non-balding areas, then see if 12 weeks of topical minoxidil 5% changes JAK2 in the balding scalp. The goal is to understand wh…